BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thornton JR, Losowsky MS. Plasma leucine enkephalin is increased in liver disease. Gut 1989;30:1392-5. [PMID: 2583565 DOI: 10.1136/gut.30.10.1392] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bergasa NV, Vergalla J, Swain MG, Jones EA. Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis. Liver 1996;16:298-302. [DOI: 10.1111/j.1600-0676.1996.tb00749.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
2 Mackinnon KL, Zuzel KA, David B. Hepatic inactivation of Leu-enkephalin. Regulatory Peptides 1996;67:85-92. [DOI: 10.1016/s0167-0115(96)00117-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Kam PCA, Tan KH. Pruritus-itching for a cause and relief? Anaesthesia 1996;51:1133-8. [DOI: 10.1111/j.1365-2044.1996.tb15050.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
4 Meixiong J, Vasavda C, Green D, Zheng Q, Qi L, Kwatra SG, Hamilton JP, Snyder SH, Dong X. Identification of a bilirubin receptor that may mediate a component of cholestatic itch. Elife 2019;8:e44116. [PMID: 30657454 DOI: 10.7554/eLife.44116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 12.7] [Reference Citation Analysis]
5 Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-9. [PMID: 1732125 DOI: 10.1016/0016-5085(92)90102-5] [Cited by in Crossref: 196] [Cited by in F6Publishing: 167] [Article Influence: 6.5] [Reference Citation Analysis]
6 Thornton JR, Losowsky MS. Plasma beta endorphin in cirrhosis and renal failure. Gut 1991;32:306-8. [PMID: 2013426 DOI: 10.1136/gut.32.3.306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
7 Ebrahimi F, Tavakoli S, Hajrasouliha AR, Sadeghipour H, Dehghani M, Ahmadi SH, Dehpour AR. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats. Fundam Clin Pharmacol 2006;20:461-71. [PMID: 16968416 DOI: 10.1111/j.1472-8206.2006.00431.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
8 Dehpour AR, Meysami F, Ebrahimi-daryani N, Akbarloo N. Inhibition by lithium of opioid withdrawal-like syndrome and physical dependency in a model of acute cholestasis in mice. Hum Psychopharmacol Clin Exp 1998;13:407-12. [DOI: 10.1002/(sici)1099-1077(199808)13:6<407::aid-hup11>3.0.co;2-c] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
9 Tennyson H, Levine N. NEUROTROPIC AND PSYCHOTROPIC DRUGS IN DERMATOLOGY. Dermatologic Clinics 2001;19:179-97. [DOI: 10.1016/s0733-8635(05)70239-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
10 Düll MM, Wolf K, Vetter M, Dietrich P, Neurath MF, Kremer AE. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus. Front Med (Lausanne) 2021;8:641163. [PMID: 33937284 DOI: 10.3389/fmed.2021.641163] [Reference Citation Analysis]
11 Nunes ACR, Amaro P, Maçôas F, Cipriano A, Martins I, Rosa A, Pimenta I, Donato A, Freitas D. Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report: . European Journal of Gastroenterology & Hepatology 2001;13:279-82. [DOI: 10.1097/00042737-200103000-00011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
12 Cao T, Tey HL, Yosipovitch G. Chronic Pruritus in the Geriatric Population. Dermatol Clin. 2018;36:199-211. [PMID: 29929593 DOI: 10.1016/j.det.2018.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Alemi F, Kwon E, Poole DP, Lieu T, Lyo V, Cattaruzza F, Cevikbas F, Steinhoff M, Nassini R, Materazzi S, Guerrero-Alba R, Valdez-Morales E, Cottrell GS, Schoonjans K, Geppetti P, Vanner SJ, Bunnett NW, Corvera CU. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest. 2013;123:1513-1530. [PMID: 23524965 DOI: 10.1172/jci64551] [Cited by in Crossref: 210] [Cited by in F6Publishing: 94] [Article Influence: 23.3] [Reference Citation Analysis]
14 Feramisco JD, Berger TG, Steinhoff M. Innovative management of pruritus. Dermatol Clin 2010;28:467-78. [PMID: 20510757 DOI: 10.1016/j.det.2010.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
15 Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2001;13:325-334. [PMID: 11338058 DOI: 10.1097/00042737-200104000-00005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
16 Chen X, Yu B, Chen M. Circulating levels of neuropeptide proenkephalin A predict outcome in patients with aneurysmal subarachnoid hemorrhage. Peptides 2014;56:111-5. [DOI: 10.1016/j.peptides.2014.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
18 Gao JB, Tang WD, Wang X, Shen J. Prognostic value of neuropeptide proenkephalin A in patients with severe traumatic brain injury. Peptides 2014;58:42-6. [PMID: 24937655 DOI: 10.1016/j.peptides.2014.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Kostopanagiotou G, Kalimeris K, Mourouzis I, Kostopanagiotou K, Arkadopoulos N, Panagopoulos D, Papoutsidakis N, Chranioti A, Pafiti A, Spanou D, Smyrniotis V, Pantos C. Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences. Endocrine 2009;36:198-204. [PMID: 19543840 DOI: 10.1007/s12020-009-9210-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
20 Khandelwal M, Malet PF. Pruritus associated with cholestasis. A review of pathogenesis and management. Dig Dis Sci 1994;39:1-8. [PMID: 8281842 DOI: 10.1007/BF02090052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Oude Elferink RP, Kremer AE, Beuers U. Mediators of pruritus during cholestasis. Curr Opin Gastroenterol. 2011;27:289-293. [PMID: 21451412 DOI: 10.1097/mog.0b013e32834575e8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
22 Patel SP, Vasavda C, Ho B, Meixiong J, Dong X, Kwatra SG. Cholestatic pruritus: Emerging mechanisms and therapeutics. J Am Acad Dermatol 2019;81:1371-8. [PMID: 31009666 DOI: 10.1016/j.jaad.2019.04.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ghaffari K, Savadkuhi ST, Honar H, Riazi K, Shafaroodi H, Moezi L, Ebrahimkhani MR, Tahmasebi MS, Dehpour AR. Obstructive cholestasis alters intestinal transit in mice: role of opioid system. Life Sci. 2004;76:397-406. [PMID: 15530502 DOI: 10.1016/j.lfs.2004.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
24 Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-22. [PMID: 12445410 DOI: 10.1016/s0168-8278(02)00318-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
25 Yang X, An H, Zhang J. Neuropeptide proenkephalin A is associated with in-hospital mortality in patients with acute intracerebral hemorrhage. Peptides 2014;58:47-51. [DOI: 10.1016/j.peptides.2014.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Bergasa NV, Mohajer B, Maisonneuve IM, Ho A, Maidment NT, Olive F, Gunduz M, Kreek MJ. Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: a study by the use of in vivo microdialysis. Life Sci 1997;61:1169-75. [PMID: 9315507 DOI: 10.1016/s0024-3205(97)00658-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
27 Grose RD, Hayes PC. Review article: the pathophysiology and pharmacological treatment of portal hypertension. Alimentary Pharmacology & Therapeutics 1992;6:521-40. [DOI: 10.1111/j.1365-2036.1992.tb00567.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Janas RM, Socha J, Warnawin K, Rujner J. Further studies on aminopeptidase-M in blood in children with cholestatic liver diseases and viral hepatitis. Dig Dis Sci 1999;44:170-6. [PMID: 9952239 DOI: 10.1023/a:1026626822298] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
29 Valeria Bergasa N, Alling DW, Vergalla J, Anthony Jones E. Cholestasis in the male rat is associated with naloxone-reversible antinociception. Journal of Hepatology 1994;20:85-90. [DOI: 10.1016/s0168-8278(05)80471-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
30 Tandon P, Rowe BH, Vandermeer B, Bain VG. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus. Am J Gastroenterology 2007;102:1528-36. [DOI: 10.1111/j.1572-0241.2007.01200.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 76] [Article Influence: 7.5] [Reference Citation Analysis]
31 Tavakoli S, Hajrasouliha AR, Jabehdar-maralani P, Ebrahimi F, Solhpour A, Sadeghipour H, Ghasemi M, Dehpour AR. Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: The roles of nitric oxide and endogenous opioid peptides. Journal of Hepatology 2007;46:432-9. [DOI: 10.1016/j.jhep.2006.09.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
32 Mani AR, Rasool R, Montagnese S, Dehpour AR. Endogenous opioids and liver disease. Scandinavian Journal of Gastroenterology 2009;41:1-11. [DOI: 10.1080/00365520500287533] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]